HQY Healthequity Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: HQY

Price (delayed)

$90.39

Market cap

$7.48B

P/E Ratio

32.4

Dividend/share

N/A

EPS

$2.79

Enterprise value

$8.19B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 92

HealthEquity and its subsidiaries administer HSAs and various other consumer-directed benefits for over 16 million accounts, working in close partnership with employers, benefits advisors, and health and retirement plan providers. With ...

Highlights
HQY's EPS has surged by 66% year-on-year and by 3.7% since the previous quarter
HQY's net income has surged by 62% year-on-year and by 2.5% since the previous quarter
HQY's quick ratio is down by 31% year-on-year and by 14% since the previous quarter
The equity has contracted by 7% YoY and by 2.8% from the previous quarter
Sector: Healthcare
Industry: Health Information Services
Website: http://www.healthequity.com
Peers: UHAL EZPW

Key stats

What are the main financial stats of HQY

HQY stock price

How has the Healthequity stock price performed over time
Intraday
-1.48%
1 week
-5.84%
1 month
-14.25%
1 year
-3.69%
YTD
-1.33%
QTD
0.08%

Financial performance

How have Healthequity's revenue and profit performed over time
Revenue
$1.36B
Gross profit
$970.48M
Operating income
$351.41M
Net income
$236.49M
Gross margin
71.2%
Net margin
17.4%
HQY's net income has surged by 62% year-on-year and by 2.5% since the previous quarter
The net margin has surged by 51% year-on-year
HQY's operating income is up by 50% year-on-year and by 2.7% since the previous quarter
Healthequity's operating margin has increased by 39% YoY

Price vs fundamentals

How does HQY's price correlate with its fundamentals

Growth

What is Healthequity's growth rate over time

Valuation

What is Healthequity stock price valuation
HQY P/E details
P/E
32.4
P/B
3.8
P/S
5.53
EV/EBIT
22.68
EV/EBITDA
15.79
EV/Sales
6.01
HQY's EPS has surged by 66% year-on-year and by 3.7% since the previous quarter
The P/E is 8% lower than the last 4 quarters average of 35.9
The stock's P/B is 17% above its 5-year quarterly average of 3.3 and 4.1% above its last 4 quarters average of 3.7
The equity has contracted by 7% YoY and by 2.8% from the previous quarter
The stock's price to sales (P/S) is 12% less than its 5-year quarterly average of 6.4 and 3.1% less than its last 4 quarters average of 5.8
HQY's revenue is up by 7% year-on-year

Efficiency

How efficient is Healthequity business performance
The ROA has soared by 69% YoY and by 4.4% from the previous quarter
The ROE has soared by 65% YoY and by 4.6% from the previous quarter
HQY's ROIC has soared by 57% YoY and by 4.4% QoQ
HQY's return on sales is up by 35% year-on-year

Dividends

What is HQY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HQY.

Financial health

How did Healthequity financials performed over time
Healthequity's total assets is 155% higher than its total liabilities
HQY's quick ratio is down by 31% year-on-year and by 14% since the previous quarter
Healthequity's current ratio has decreased by 29% YoY and by 13% QoQ
The debt is 51% smaller than the equity
The debt has declined by 8% year-on-year
The equity has contracted by 7% YoY and by 2.8% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.